[S02DA03, antipyrine, The risk or severity of bleeding can be increased when Antipyrine is combined with Pentoxifylline.]
[B01AD01, streptokinase, The therapeutic efficacy of Streptokinase can be increased when used in combination with Pentoxifylline.]
[J01GA01, streptomycin, Pentoxifylline may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[L01AD04, streptozocin, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Streptozocin.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01CG01, sulbactam, Pentoxifylline may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, Sulfadiazine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, Pentoxifylline may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.]
[M04AB02, sulfinpyrazone, Pentoxifylline may increase the antiplatelet activities of Sulfinpyrazone.]
[M01AB02, sulindac, The risk or severity of bleeding can be increased when Sulindac is combined with Pentoxifylline.]
[N03AX03, sulthiame, Sulthiame may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AX04, apazone, The risk or severity of bleeding can be increased when Azapropazone is combined with Pentoxifylline.]
[L01BB02, mercaptopurine, The serum concentration of Mercaptopurine can be increased when it is combined with Pentoxifylline.]
[N06DA01, tacrine, The metabolism of Pentoxifylline can be decreased when combined with Tacrine.]
[L02BA01, tamoxifen, The metabolism of Pentoxifylline can be decreased when combined with Tamoxifen.]
[N05CD07, temazepam, The therapeutic efficacy of Temazepam can be decreased when used in combination with Pentoxifylline.]
[L01CB02, teniposide, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Teniposide.]
[R03CC03, terbutaline, The risk or severity of adverse effects can be increased when Terbutaline is combined with Pentoxifylline.]
[B01AE07, dabigatran etexilate, The therapeutic efficacy of Dabigatran etexilate can be increased when used in combination with Pentoxifylline.]
[G03BA03, testosterone, Testosterone may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[S03AA02, tetracycline, Tetracycline may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[A04AD10, dronabinol, The metabolism of Pentoxifylline can be decreased when combined with Dronabinol.]
[L04AX02, thalidomide, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Thalidomide.]
[R03DA07, theobromine, The serum concentration of Theobromine can be increased when it is combined with Pentoxifylline.]
[R03DA04, theophylline, The serum concentration of Theophylline can be increased when it is combined with Pentoxifylline.]
[P02CA02, thiabendazole, The metabolism of Pentoxifylline can be decreased when combined with Thiabendazole.]
[L01XX41, eribulin, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Eribulin.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[L01AC01, thiotepa, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Thiotepa.]
[L01BB03, thioguanine, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Tioguanine.]
[N05CA19, thiopental, The serum concentration of Pentoxifylline can be decreased when it is combined with Thiopental.]
[N05AF04, thiothixene, The metabolism of Thiothixene can be decreased when combined with Pentoxifylline.]
[G04BE06, moxisylyte, Pentoxifylline may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Pentoxifylline may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, Pentoxifylline may increase the antiplatelet activities of Ticlopidine.]
[S01ED01, timolol, Pentoxifylline may increase the hypotensive activities of Timolol.]
[P01AB02, tinidazole, Pentoxifylline may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01AA12, tobramycin, Pentoxifylline may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Pentoxifylline may decrease the excretion rate of Tolazamide which could result in a higher serum level.]
[M02AX02, tolazoline, Pentoxifylline may increase the hypotensive activities of Tolazoline.]
[V04CA01, tolbutamide, Pentoxifylline may decrease the excretion rate of Tolbutamide which could result in a higher serum level.]
[M02AA21, tolmetin, The risk or severity of bleeding can be increased when Tolmetin is combined with Pentoxifylline.]
[N02AX02, tramadol, Tramadol may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N06AF04, tranylcypromine, The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Pentoxifylline.]
[C01DX11, trapidil, Pentoxifylline may increase the antiplatelet activities of Trapidil.]
[N06AX05, trazodone, The risk or severity of bleeding can be increased when Trazodone is combined with Pentoxifylline.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, The therapeutic efficacy of Triazolam can be decreased when used in combination with Pentoxifylline.]
[C03AA06, trichlormethiazide, Pentoxifylline may increase the hypotensive activities of Trichlormethiazide.]
[A16AX12, trientine, Pentoxifylline may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[N05AB06, trifluoperazine, The metabolism of Trifluoperazine can be decreased when combined with Pentoxifylline.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[A03AA05, trimebutine, Pentoxifylline may decrease the excretion rate of Trimebutine which could result in a higher serum level.]
[N03AC02, trimethadione, Trimethadione may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[C02BA01, trimethaphan, Pentoxifylline may increase the hypotensive activities of Trimethaphan.]
[J01EA01, trimethoprim, Trimethoprim may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01FA08, troleandomycin, The metabolism of Pentoxifylline can be decreased when combined with Troleandomycin.]
[C09CA09, azilsartan medoxomil, Pentoxifylline may increase the hypotensive activities of Azilsartan medoxomil.]
[R03DX07, roflumilast, The metabolism of Roflumilast can be decreased when combined with Pentoxifylline.]
[L01FX04, ipilimumab, Pentoxifylline may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[R02AA14, oxyquinoline, Pentoxifylline may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[L02BX03, abiraterone, The serum concentration of Pentoxifylline can be increased when it is combined with Abiraterone.]
[B01AD04, urokinase, Pentoxifylline may increase the anticoagulant activities of Urokinase.]
[S01AA28, vancomycin, Pentoxifylline may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Ezogabine may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AF01, rivaroxaban, Pentoxifylline may increase the anticoagulant activities of Rivaroxaban.]
[R03AC18, indacaterol, The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Indacaterol.]
[B01AC24, ticagrelor, The therapeutic efficacy of Ticagrelor can be increased when used in combination with Pentoxifylline.]
[C08DA01, verapamil, The metabolism of Pentoxifylline can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Pentoxifylline can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Vinblastine.]
[C04AX07, vincamine, Pentoxifylline may increase the hypotensive activities of Vincamine.]
[L01CA03, vindesine, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Vindesine.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[A11HA03, vitamin E, Vitamin E may increase the antiplatelet activities of Pentoxifylline.]
[B01AA03, warfarin, The therapeutic efficacy of Warfarin can be increased when used in combination with Pentoxifylline.]
[C03BA10, xipamide, Pentoxifylline may increase the hypotensive activities of Xipamide.]
[J05AF01, zidovudine, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Zidovudine.]
[N03AX14, levetiracetam, Levetiracetam may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[L01EC01, vemurafenib, The serum concentration of Pentoxifylline can be increased when it is combined with Vemurafenib.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[M05BA05, tiludronic acid, Pentoxifylline may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[B06AC02, icatibant, Pentoxifylline may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[B01AE01, desirudin, The therapeutic efficacy of Lepirudin can be increased when used in combination with Pentoxifylline.]
[R03DC01, zafirlukast, The serum concentration of Zafirlukast can be decreased when it is combined with Pentoxifylline.]
[A02BC04, rabeprazole, Pentoxifylline may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[J01MA13, trovafloxacin, The metabolism of Pentoxifylline can be decreased when combined with Trovafloxacin.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Pentoxifylline may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[L04AA34, alemtuzumab, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Alemtuzumab.]
[N02BA01, aspirin, Acetylsalicylic acid may increase the antiplatelet activities of Pentoxifylline.]
[L01EJ01, ruxolitinib, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Ruxolitinib.]
[G04BD07, tolterodine, Pentoxifylline may decrease the excretion rate of Tolterodine which could result in a higher serum level.]
[J01DH04, doripenem, Pentoxifylline may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[C07AB03, atenolol, Pentoxifylline may increase the hypotensive activities of Atenolol.]
[L03AB11, peginterferon alfa-2a, The metabolism of Pentoxifylline can be decreased when combined with Peginterferon alfa-2a.]
[L01FA01, rituximab, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Rituximab.]
[M01CB03, auranofin, Pentoxifylline may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Pentoxifylline.]
[B03XA04, peginesatide, Pentoxifylline may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Azacitidine.]
[L04AX01, azathioprine, The metabolism of Azathioprine can be decreased when combined with Pentoxifylline.]
[L01BC05, gemcitabine, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Gemcitabine.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[M03BX01, baclofen, Baclofen may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Gemtuzumab ozogamicin.]
[A08AA11, lorcaserin, The metabolism of Lorcaserin can be decreased when combined with Pentoxifylline.]
[G04BD12, mirabegron, Pentoxifylline may decrease the excretion rate of Mirabegron which could result in a higher serum level.]
[L01XG02, carfilzomib, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Carfilzomib.]
[L02BB04, enzalutamide, Pentoxifylline may decrease the excretion rate of Enzalutamide which could result in a higher serum level.]
[L01EA04, bosutinib, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Bosutinib.]
[L04AA31, teriflunomide, The serum concentration of Pentoxifylline can be decreased when it is combined with Teriflunomide.]
[B01AX01, defibrotide, The therapeutic efficacy of Defibrotide can be increased when used in combination with Pentoxifylline.]
[N05CA04, barbital, The serum concentration of Pentoxifylline can be decreased when it is combined with Barbital.]
[D02BA02, octinoxate, Pentoxifylline may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[L01AA09, bendamustine, The metabolism of Bendamustine can be decreased when combined with Pentoxifylline.]
[N04BD02, rasagiline, The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Pentoxifylline.]
[C08CA13, lercanidipine, Pentoxifylline may increase the hypotensive activities of Lercanidipine.]
[N03AX22, perampanel, Perampanel may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AA29, tofacitinib, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Tofacitinib.]
[N02CC03, zolmitriptan, The metabolism of Pentoxifylline can be decreased when combined with Zolmitriptan.]
[V09IX04, fluorodeoxyglucose F18, Pentoxifylline may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[V08CA11, gadofosveset, Pentoxifylline may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Ponatinib.]
[B01AF02, apixaban, The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Apixaban.]
[A16AX08, teduglutide, Pentoxifylline may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[A10BH04, alogliptin, Pentoxifylline may decrease the excretion rate of Alogliptin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Pentoxifylline may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, Pentoxifylline may increase the hypotensive activities of Bendroflumethiazide.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be decreased when combined with Pentoxifylline.]
[N02BA10, benorilate, The risk or severity of bleeding can be increased when Benorilate is combined with Pentoxifylline.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[J01MA15, gemifloxacin, The metabolism of Pentoxifylline can be decreased when combined with Gemifloxacin.]
[S01AE07, moxifloxacin, The metabolism of Pentoxifylline can be decreased when combined with Moxifloxacin.]
[A06AX06, tegaserod, The metabolism of Pentoxifylline can be decreased when combined with Tegaserod.]
[H03AA04, tiratricol, Tiratricol may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AE05, insulin detemir, The risk or severity of hypoglycemia can be increased when Pentoxifylline is combined with Insulin detemir.]
[R02AD01, benzocaine, The metabolism of Benzocaine can be decreased when combined with Pentoxifylline.]
[L03AA12, ancestim, Pentoxifylline may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, The risk or severity of bleeding can be increased when Celecoxib is combined with Pentoxifylline.]
[L04AA18, everolimus, The metabolism of Pentoxifylline can be decreased when combined with Everolimus.]
[L03AB03, gamma-interferon, The metabolism of Pentoxifylline can be decreased when combined with Interferon Gamma.]
[N04AC01, benztropine, Benzatropine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[R02AX03, benzydamine, The risk or severity of bleeding can be increased when Benzydamine is combined with Pentoxifylline.]
[L01EE01, trametinib, Pentoxifylline may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[P03AX06, benzyl alcohol, The metabolism of Benzyl alcohol can be decreased when combined with Pentoxifylline.]
[V09AX05, florbetapir F-18, Pentoxifylline may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Pentoxifylline.]
[C08EA02, bepridil, Pentoxifylline may increase the hypotensive activities of Bepridil.]
[C02KX05, riociguat, Pentoxifylline may increase the hypotensive activities of Riociguat.]
[A10BJ03, lixisenatide, Pentoxifylline may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[A05AA03, cholic acid, The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Cholic Acid.]
[C02KX04, macitentan, Pentoxifylline may increase the hypotensive activities of Macitentan.]
[L01EL01, ibrutinib, The risk or severity of adverse effects can be increased when Ibrutinib is combined with Pentoxifylline.]
[N06AX26, vortioxetine, The risk or severity of bleeding can be increased when Vortioxetine is combined with Pentoxifylline.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N03AF04, eslicarbazepine, Eslicarbazepine may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AP05, simeprevir, The metabolism of Pentoxifylline can be decreased when combined with Simeprevir.]
[J05AP08, sofosbuvir, Pentoxifylline may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[N03AG04, vigabatrin, Vigabatrin may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Pentoxifylline may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[C07AB04, acebutolol, Pentoxifylline may increase the hypotensive activities of Acebutolol.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be decreased when combined with Pentoxifylline.]
[L04AA32, apremilast, The metabolism of Pentoxifylline can be increased when combined with Apremilast.]
[L02BG02, formestane, Pentoxifylline may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S01ED02, betaxolol, Pentoxifylline may increase the hypotensive activities of Betaxolol.]
[B01AE03, argatroban, The therapeutic efficacy of Argatroban can be increased when used in combination with Pentoxifylline.]
[V03AB34, fomepizole, Pentoxifylline may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[C02CC01, bethanidine, Pentoxifylline may increase the hypotensive activities of Bethanidine.]
[L04AC11, siltuximab, The metabolism of Pentoxifylline can be increased when combined with Siltuximab.]
[B01AC26, vorapaxar, The therapeutic efficacy of Vorapaxar can be increased when used in combination with Pentoxifylline.]
[B01AA07, acenocoumarol, The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Pentoxifylline.]
[L01XH04, belinostat, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Belinostat.]
[R03AC19, olodaterol, Pentoxifylline may increase the hyperkalemic activities of Olodaterol.]
[L03AB13, peginterferon beta-1a, The metabolism of Pentoxifylline can be decreased when combined with Peginterferon beta-1a.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[L01BC08, decitabine, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Decitabine.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Pentoxifylline.]
[S03AA06, gentamicin, Pentoxifylline may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[L01FX07, blinatumomab, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Blinatumomab.]
[L01XK01, olaparib, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Olaparib.]
[B01AA01, dicumarol, The therapeutic efficacy of Dicoumarol can be increased when used in combination with Pentoxifylline.]
[B01AF03, edoxaban, The therapeutic efficacy of Edoxaban can be increased when used in combination with Pentoxifylline.]
[N06AX11, mirtazapine, The metabolism of Pentoxifylline can be decreased when combined with Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Pentoxifylline can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Palbociclib.]
[N02BE01, acetaminophen, The metabolism of Pentoxifylline can be decreased when combined with Acetaminophen.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[B01AA11, tioclomarol, The therapeutic efficacy of Tioclomarol can be increased when used in combination with Pentoxifylline.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[B01AC25, cangrelor, The therapeutic efficacy of Cangrelor can be increased when used in combination with Pentoxifylline.]
[M02AA25, aceclofenac, The risk or severity of bleeding can be increased when Aceclofenac is combined with Pentoxifylline.]
[M01AB11, acemetacin, The risk or severity of bleeding can be increased when Acemetacin is combined with Pentoxifylline.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AE06, insulin degludec, The risk or severity of hypoglycemia can be increased when Pentoxifylline is combined with Insulin degludec.]
[V03AB37, idarucizumab, Pentoxifylline may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[L01CX01, trabectedin, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Trabectedin.]
[L01EB04, osimertinib, The serum concentration of Pentoxifylline can be decreased when it is combined with Osimertinib.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Pentoxifylline.]
[L01XG03, ixazomib, Pentoxifylline may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[B01AC27, selexipag, Pentoxifylline may increase the hypotensive activities of Selexipag.]
[M04AB05, lesinurad, Pentoxifylline may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[M01AE16, alminoprofen, The risk or severity of bleeding can be increased when Alminoprofen is combined with Pentoxifylline.]
[N02BA02, aloxiprin, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Aloxiprin.]
[N03AX23, brivaracetam, Brivaracetam may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA08, bromazepam, The therapeutic efficacy of Bromazepam can be decreased when used in combination with Pentoxifylline.]
[A02AD05, aluminum magnesium silicate, Pentoxifylline may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[C08CA01, amlodipine, Pentoxifylline may increase the hypotensive activities of Amlodipine.]
[A05AA04, obeticholic acid, The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Obeticholic acid.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, The metabolism of Levobupivacaine can be decreased when combined with Pentoxifylline.]
[C07AA19, bupranolol, Pentoxifylline may increase the hypotensive activities of Bupranolol.]
[N05BE01, buspirone, Buspirone may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[L01AB01, busulfan, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Busulfan.]
[L01XX27, arsenic trioxide, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Arsenic trioxide.]
[M02AA03, clofezone, Pentoxifylline may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[J01MA09, sparfloxacin, The metabolism of Pentoxifylline can be decreased when combined with Sparfloxacin.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Pentoxifylline.]
[L01XK03, rucaparib, The metabolism of Pentoxifylline can be increased when combined with Rucaparib.]
[A07EC04, balsalazide, The risk or severity of bleeding can be increased when Balsalazide is combined with Pentoxifylline.]
[R03CC12, bambuterol, The risk or severity of hypokalemia can be increased when Pentoxifylline is combined with Bambuterol.]
[R03DA08, bamifylline, The serum concentration of Bamifylline can be increased when it is combined with Pentoxifylline.]
[A06AH05, naldemedine, Pentoxifylline may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Pentoxifylline may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Pregabalin may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AX30, beclamide, Beclamide may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BC01, caffeine, The serum concentration of Caffeine can be increased when it is combined with Pentoxifylline.]
[C09AA07, benazepril, Pentoxifylline may increase the hypotensive activities of Benazepril.]
[P01CA02, benznidazole, Pentoxifylline may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J01XX08, linezolid, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Pentoxifylline.]
[J05AF06, abacavir, Pentoxifylline may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[J05AE09, tipranavir, Tipranavir may increase the antiplatelet activities of Pentoxifylline.]
[H03BA03, benzylthiouracil, Benzylthiouracil may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N07XX13, valbenazine, Pentoxifylline may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[L04AB02, infliximab, The metabolism of Pentoxifylline can be increased when combined with Infliximab.]
[N04BD03, safinamide, The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Pentoxifylline.]
[J01MA23, delafloxacin, The metabolism of Pentoxifylline can be decreased when combined with Delafloxacin.]
[B01AF04, betrixaban, The therapeutic efficacy of Betrixaban can be increased when used in combination with Pentoxifylline.]
[L01BC06, capecitabine, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Capecitabine.]
[L01XX59, enasidenib, The metabolism of Pentoxifylline can be decreased when combined with Enasidenib.]
[L01XH01, vorinostat, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Vorinostat.]
[C07AB07, bisoprolol, Pentoxifylline may increase the hypotensive activities of Bisoprolol.]
[R03AC17, bitolterol, The risk or severity of hypokalemia can be increased when Pentoxifylline is combined with Bitolterol.]
[J05AG03, efavirenz, The metabolism of Pentoxifylline can be decreased when combined with Efavirenz.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[C07AA17, bopindolol, The risk or severity of adverse effects can be increased when Bopindolol is combined with Pentoxifylline.]
[L01BA03, raltitrexed, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Raltitrexed.]
[N05CD09, brotizolam, The therapeutic efficacy of Brotizolam can be decreased when used in combination with Pentoxifylline.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, Pentoxifylline may decrease the excretion rate of Budesonide which could result in a higher serum level.]
[C04AX20, buflomedil, Pentoxifylline may increase the antiplatelet activities of Buflomedil.]
[M01AB07, bumadizone, The risk or severity of bleeding can be increased when Bumadizone is combined with Pentoxifylline.]
[N01BX04, capsaicin, The metabolism of Pentoxifylline can be increased when combined with Capsaicin.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, Pentoxifylline may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[C09AA01, captopril, Pentoxifylline may increase the hypotensive activities of Captopril.]
[L02BB05, apalutamide, Pentoxifylline may decrease the excretion rate of Apalutamide which could result in a higher serum level.]
[N03AF01, carbamazepine, The serum concentration of Pentoxifylline can be decreased when it is combined with Carbamazepine.]
[H03BB01, carbimazole, Carbimazole may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[L03AB06, interferon alfa-n1, The metabolism of Pentoxifylline can be decreased when combined with Interferon alfa-n1.]
[C07AG02, carvedilol, Pentoxifylline may increase the hypotensive activities of Carvedilol.]
[N03AX24, cannabidiol, Cannabidiol may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AA37, baricitinib, Pentoxifylline may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[L01EE03, binimetinib, The metabolism of Binimetinib can be decreased when combined with Pentoxifylline.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01GB14, plazomicin, Pentoxifylline may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[C07AB08, celiprolol, Pentoxifylline may increase the hypotensive activities of Celiprolol.]
[A16AX14, migalastat, Pentoxifylline may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, Stiripentol may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[D08AE05, chloroxylenol, Pentoxifylline may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, The risk or severity of bleeding can be increased when Lornoxicam is combined with Pentoxifylline.]
[R03DA02, oxtriphylline, The serum concentration of Oxtriphylline can be increased when it is combined with Pentoxifylline.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[L04AA39, emapalumab, The metabolism of Pentoxifylline can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The metabolism of Pentoxifylline can be decreased when combined with Carmustine.]
[A06AX05, prucalopride, Pentoxifylline may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C09AA08, cilazapril, Pentoxifylline may increase the hypotensive activities of Cilazapril.]
[B01AX07, caplacizumab, Pentoxifylline may increase the antiplatelet activities of Caplacizumab.]
[B01AC23, cilostazol, Pentoxifylline may increase the antiplatelet activities of Cilostazol.]
[P02BX04, triclabendazole, The metabolism of Pentoxifylline can be decreased when combined with Triclabendazole.]
[J01FA09, clarithromycin, The metabolism of Pentoxifylline can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, Pentoxifylline may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[N06AX29, brexanolone, Brexanolone may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA09, clobazam, The therapeutic efficacy of Clobazam can be decreased when used in combination with Pentoxifylline.]
[N05BA22, cloxazolam, The therapeutic efficacy of Cloxazolam can be decreased when used in combination with Pentoxifylline.]
[C09CA06, candesartan, Pentoxifylline may increase the hypotensive activities of Candesartan.]
[L04AB01, etanercept, The metabolism of Pentoxifylline can be increased when combined with Etanercept.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[C03BX03, cicletanine, Pentoxifylline may increase the hypotensive activities of Cicletanine.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[M03BX08, cyclobenzaprine, The metabolism of Cyclobenzaprine can be decreased when combined with Pentoxifylline.]
[N07XX11, pitolisant, The metabolism of Pentoxifylline can be increased when combined with Pitolisant.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Pentoxifylline.]
[C03AA09, cyclothiazide, Pentoxifylline may increase the hypotensive activities of Cyclothiazide.]
[A10AE03, insulin, regular, pork, The risk or severity of hypoglycemia can be increased when Pentoxifylline is combined with Insulin pork.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[L01FD03, ado-trastuzumab emtansine, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Trastuzumab emtansine.]
[N03AX25, cenobamate, Cenobamate may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX16, givosiran, The serum concentration of Pentoxifylline can be increased when it is combined with Givosiran.]
[M09AX08, golodirsen, Pentoxifylline may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Pentoxifylline may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[M01AX21, diacetylrhein, The metabolism of Pentoxifylline can be decreased when combined with Diacerein.]
[S01AE06, gatifloxacin, The metabolism of Pentoxifylline can be decreased when combined with Gatifloxacin.]
[H02CA02, osilodrostat, The metabolism of Pentoxifylline can be decreased when combined with Osilodrostat.]
[N02CC07, frovatriptan, The metabolism of Frovatriptan can be decreased when combined with Pentoxifylline.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Pentoxifylline.]
[R02AA03, dichlorobenzyl alcohol, Pentoxifylline may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Pentoxifylline may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[M01AH02, rofecoxib, The serum concentration of Pentoxifylline can be increased when it is combined with Rofecoxib.]
[L01XF03, bexarotene, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Bexarotene.]
[C08CA16, clevidipine, Pentoxifylline may decrease the excretion rate of Clevidipine which could result in a higher serum level.]
[S01EA02, dipivefrin, The risk or severity of hypokalemia can be increased when Pentoxifylline is combined with Dipivefrin.]
[N03AG02, dipropylacetamide, Valpromide may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[J01FA13, dirithromycin, The metabolism of Pentoxifylline can be decreased when combined with Dirithromycin.]
[L01AA02, chlorambucil, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Chlorambucil.]
[S03AA08, chloramphenicol, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Chloramphenicol.]
[N05BA02, chlordiazepoxide, The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Pentoxifylline.]
[C02AA06, methoserpidine, Pentoxifylline may increase the hypotensive activities of Methoserpidine.]
[L01EX17, capmatinib, The metabolism of Pentoxifylline can be decreased when combined with Capmatinib.]
[M01AC04, droxicam, The risk or severity of bleeding can be increased when Droxicam is combined with Pentoxifylline.]
[V08CA05, mangafodipir, Pentoxifylline may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[B01AE02, lepirudin, The therapeutic efficacy of Lepirudin can be increased when used in combination with Pentoxifylline.]
[M02AA27, dexketoprofen, The risk or severity of bleeding can be increased when Dexketoprofen is combined with Pentoxifylline.]
[N05CM02, chlormethiazole, Clomethiazole may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA17, levamlodipine, Pentoxifylline may increase the hypotensive activities of Levamlodipine.]
[N05CD14, remimazolam, The therapeutic efficacy of Remimazolam can be decreased when used in combination with Pentoxifylline.]
[L04AC19, satralizumab, The serum concentration of Pentoxifylline can be decreased when it is combined with Satralizumab.]
[P01BA01, chloroquine, Chloroquine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[C03AA04, chlorothiazide, Pentoxifylline may increase the hypotensive activities of Chlorothiazide.]
[N05AA01, chlorpromazine, The metabolism of Pentoxifylline can be decreased when combined with Chlorpromazine.]
[A10BB02, chlorpropamide, Chlorpropamide may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[C03BA04, chlorthalidone, Pentoxifylline may increase the hypotensive activities of Chlorthalidone.]
[M03BB03, chlorzoxazone, The metabolism of Pentoxifylline can be decreased when combined with Chlorzoxazone.]
[N02BA07, ethenzamide, The risk or severity of bleeding can be increased when Ethenzamide is combined with Pentoxifylline.]
[N02BA03, choline salicylate, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Choline salicylate.]
[N06BX18, vinpocetine, Vinpocetine may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA18, ethyl loflazepate, The therapeutic efficacy of Ethyl loflazepate can be decreased when used in combination with Pentoxifylline.]
[M01AB08, etodolac, The risk or severity of bleeding can be increased when Etodolac is combined with Pentoxifylline.]
[M02AA06, etofenamate, The risk or severity of bleeding can be increased when Etofenamate is combined with Pentoxifylline.]
[L01BB05, fludarabine, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Fludarabine.]
[M01AX25, chondroitin sulfates, Pentoxifylline may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[P03AX07, abametapir, The serum concentration of Pentoxifylline can be increased when it is combined with Abametapir.]
[V03AF12, trilaciclib, The metabolism of Pentoxifylline can be increased when combined with Trilaciclib.]
[N03AX10, felbamate, Felbamate may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AE05, fenbufen, The risk or severity of bleeding can be increased when Fenbufen is combined with Pentoxifylline.]
[N06BA10, fenethylline, The serum concentration of Fenethylline can be increased when it is combined with Pentoxifylline.]
[C01CA19, fenoldopam, Pentoxifylline may increase the hypotensive activities of Fenoldopam.]
[N06BA08, fenozolone, The risk or severity of adverse effects can be increased when Fenozolone is combined with Pentoxifylline.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01MB07, flumequine, The metabolism of Pentoxifylline can be decreased when combined with Flumequine.]
[S02BA08, fluocinolone acetonide, Fluocinolone acetonide may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N02BG07, flupirtine, Pentoxifylline may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[R03CC15, formoterol, The risk or severity of hypokalemia can be increased when Pentoxifylline is combined with Formoterol.]
[A10AF01, insulin, regular, human, The risk or severity of hypoglycemia can be increased when Pentoxifylline is combined with Insulin human.]
[L03AB10, peginterferon alfa-2b, The serum concentration of Pentoxifylline can be increased when it is combined with Peginterferon alfa-2b.]
[H04AA02, dasiglucagon, Pentoxifylline may increase the hypotensive activities of Dasiglucagon.]
[A02BA01, cimetidine, The serum concentration of Pentoxifylline can be increased when it is combined with Cimetidine.]
[N02BF01, gabapentin, Gabapentin may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N07CA02, cinnarizine, The metabolism of Pentoxifylline can be decreased when combined with Cinnarizine.]
[J01MB06, cinoxacin, The metabolism of Pentoxifylline can be decreased when combined with Cinoxacin.]
[S03AA07, ciprofloxacin, The serum concentration of Pentoxifylline can be increased when it is combined with Ciprofloxacin.]
[L01XA01, cisplatin, Pentoxifylline may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[N06AB04, citalopram, The risk or severity of hemorrhage can be increased when Citalopram is combined with Pentoxifylline.]
[H01AC07, somapacitan, The metabolism of Pentoxifylline can be increased when combined with Somapacitan.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[P01CA03, fexinidazole, The metabolism of Pentoxifylline can be decreased when combined with Fexinidazole.]
[H01AC09, lonapegsomatropin, The metabolism of Pentoxifylline can be increased when combined with Lonapegsomatropin.]
[V09AB03, ioflupane I-123, Pentoxifylline may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Pentoxifylline may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Pentoxifylline may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[M01AG01, mefenamic acid, The risk or severity of bleeding can be increased when Mefenamic acid is combined with Pentoxifylline.]
[R03CC13, clenbuterol, The risk or severity of adverse effects can be increased when Clenbuterol is combined with Pentoxifylline.]
[J01FF01, clindamycin, The metabolism of Pentoxifylline can be decreased when combined with Clindamycin.]
[L03AB15, ropeginterferon alfa-2b, The metabolism of Pentoxifylline can be decreased when combined with Ropeginterferon alfa-2b.]
[D11AH08, abrocitinib, The risk or severity of bleeding and thrombocytopenia can be increased when Pentoxifylline is combined with Abrocitinib.]
[B01AD11, tenecteplase, The therapeutic efficacy of Tenecteplase can be increased when used in combination with Pentoxifylline.]
[N01BB10, levobupivacaine, The metabolism of Levobupivacaine can be decreased when combined with Pentoxifylline.]
[L01EJ03, pacritinib, The metabolism of Pentoxifylline can be decreased when combined with Pacritinib.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Pentoxifylline.]
[N03AE01, clonazepam, The therapeutic efficacy of Clonazepam can be decreased when used in combination with Pentoxifylline.]
[S01EA04, clonidine, Pentoxifylline may increase the hypotensive activities of Clonidine.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA21, clotiazepam, The therapeutic efficacy of Clotiazepam can be decreased when used in combination with Pentoxifylline.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Pentoxifylline.]
[N05AH02, clozapine, The metabolism of Pentoxifylline can be decreased when combined with Clozapine.]
[J01GB12, arbekacin, Pentoxifylline may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[N05BA13, halazepam, The therapeutic efficacy of Halazepam can be decreased when used in combination with Pentoxifylline.]
[H01AC08, somatrogon, The metabolism of Pentoxifylline can be increased when combined with Somatrogon.]
[C02KB01, metyrosine, Pentoxifylline may increase the hypotensive activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Pentoxifylline can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, The risk or severity of bleeding can be increased when Proquazone is combined with Pentoxifylline.]
[M04AC01, colchicine, Pentoxifylline may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[J01XB01, colistin, Pentoxifylline may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[L04AA13, leflunomide, The serum concentration of Pentoxifylline can be decreased when it is combined with Leflunomide.]
[A04AA03, tropisetron, Pentoxifylline may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[C04AX28, ifenprodil, Ifenprodil may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BX03, nateglinide, Nateglinide may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of bleeding can be increased when Imidazole salicylate is combined with Pentoxifylline.]
[L01BB07, nelarabine, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Nelarabine.]
[A10AE04, insulin glargine, The risk or severity of hypoglycemia can be increased when Pentoxifylline is combined with Insulin glargine.]
[B01AC10, indobufen, Pentoxifylline may increase the antiplatelet activities of Indobufen.]
[J05AB14, valganciclovir, Pentoxifylline may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Pentoxifylline may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Pentoxifylline may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Pentoxifylline may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Pentoxifylline may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Pentoxifylline may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, The risk or severity of bleeding can be increased when Valdecoxib is combined with Pentoxifylline.]
[N02CC05, almotriptan, Pentoxifylline may decrease the excretion rate of Almotriptan which could result in a higher serum level.]
[M01AH04, parecoxib, The risk or severity of bleeding can be increased when Parecoxib is combined with Pentoxifylline.]
[B01AB12, bemiparin, The therapeutic efficacy of Bemiparin can be increased when used in combination with Pentoxifylline.]
[S01AD03, acyclovir, The metabolism of Pentoxifylline can be decreased when combined with Acyclovir.]
[N05BA10, ketazolam, The therapeutic efficacy of Ketazolam can be decreased when used in combination with Pentoxifylline.]
[M01AA06, kebuzone, The risk or severity of bleeding can be increased when Kebuzone is combined with Pentoxifylline.]
[L01EA01, imatinib, The metabolism of Pentoxifylline can be decreased when combined with Imatinib.]
[C08CA09, lacidipine, Pentoxifylline may increase the hypotensive activities of Lacidipine.]
[N03AX09, lamotrigine, Lamotrigine may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N07BC04, lofexidine, Pentoxifylline may increase the hypotensive activities of Lofexidine.]
[S01AE04, lomefloxacin, The metabolism of Pentoxifylline can be decreased when combined with Lomefloxacin.]
[M01AB09, lonazolac, The risk or severity of bleeding can be increased when Lonazolac is combined with Pentoxifylline.]
[N05CD06, lormetazepam, The therapeutic efficacy of Lormetazepam can be decreased when used in combination with Pentoxifylline.]
[M02AA31, loxoprofen, The risk or severity of bleeding can be increased when Loxoprofen is combined with Pentoxifylline.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[C09AA03, lisinopril, Pentoxifylline may increase the hypotensive activities of Lisinopril.]
[A06AD01, magnesium carbonate, Pentoxifylline may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[C08CA11, manidipine, Pentoxifylline may increase the hypotensive activities of Manidipine.]
[A08AA09, mefenorex, The risk or severity of adverse effects can be increased when Mefenorex is combined with Pentoxifylline.]
[C07AA14, mepindolol, The risk or severity of adverse effects can be increased when Mepindolol is combined with Pentoxifylline.]
[J01DH02, meropenem, Meropenem may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[C01EB10, adenosine, The therapeutic efficacy of Adenosine can be decreased when used in combination with Pentoxifylline.]
[R03CB02, methoxyphenamine, The risk or severity of adverse effects can be increased when Methoxyphenamine is combined with Pentoxifylline.]
[C03DA04, eplerenone, Pentoxifylline may increase the hypotensive activities of Eplerenone.]
[N05AD03, metylperon, Pentoxifylline may decrease the excretion rate of Melperone which could result in a higher serum level.]
[C03AA07, cyclopenthiazide, Pentoxifylline may increase the hypotensive activities of Cyclopenthiazide.]
[J01FA03, midecamycin, The metabolism of Pentoxifylline can be decreased when combined with Midecamycin.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[L01AA01, cyclophosphamide, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Cyclophosphamide.]
[N06AX07, minaprine, The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Pentoxifylline.]
[S01XA18, cyclosporine, Cyclosporine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N06AG02, moclobemide, The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Pentoxifylline.]
[N06BA07, modafinil, The metabolism of Pentoxifylline can be increased when combined with Armodafinil.]
[C09AA13, moexipril, Pentoxifylline may increase the hypotensive activities of Moexipril.]
[M02AA02, mofebutazone, The risk or severity of bleeding can be increased when Mofebutazone is combined with Pentoxifylline.]
[M01AX22, morniflumate, The risk or severity of bleeding can be increased when Morniflumate is combined with Pentoxifylline.]
[C03XA02, conivaptan, Conivaptan may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AC05, moxonidine, Pentoxifylline may increase the hypotensive activities of Moxonidine.]
[L01BC01, cytarabine, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Cytarabine.]
[J05AF10, entecavir, The metabolism of Pentoxifylline can be decreased when combined with Entecavir.]
[M01AH05, etoricoxib, The risk or severity of bleeding can be increased when Etoricoxib is combined with Pentoxifylline.]
[L01AX04, dacarbazine, The metabolism of Dacarbazine can be decreased when combined with Pentoxifylline.]
[L01DA01, dactinomycin, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Dactinomycin.]
[L01DB02, daunorubicin, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Daunorubicin.]
[C02CC04, debrisoquin, Pentoxifylline may increase the hypotensive activities of Debrisoquine.]
[M01AX01, nabumetone, The risk or severity of gastrointestinal irritation can be increased when Pentoxifylline is combined with Nabumetone.]
[N07BB05, nalmefene, Pentoxifylline may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[N05BA16, nordazepam, The therapeutic efficacy of Nordazepam can be decreased when used in combination with Pentoxifylline.]
[C07AB12, nebivolol, Pentoxifylline may increase the hypotensive activities of Nebivolol.]
[S01GX04, nedocromil, Nedocromil may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N06AX06, nefazodone, The risk or severity of hemorrhage can be increased when Nefazodone is combined with Pentoxifylline.]
[C01DX16, nicorandil, Pentoxifylline may increase the hypotensive activities of Nicorandil.]
[L02BB02, nilutamide, Nilutamide may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N03AG06, tiagabine, Tiagabine may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA23, theodrenaline, The serum concentration of Theodrenaline can be increased when it is combined with Pentoxifylline.]
[B01AX05, fondaparinux, The therapeutic efficacy of Fondaparinux can be increased when used in combination with Pentoxifylline.]
[N06AB10, escitalopram, The risk or severity of bleeding can be increased when Escitalopram is combined with Pentoxifylline.]
[A07EC03, olsalazine, The risk or severity of bleeding can be increased when Olsalazine is combined with Pentoxifylline.]
[N06AA01, desipramine, Pentoxifylline may decrease the excretion rate of Desipramine which could result in a higher serum level.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[V04CH02, indigo carmine, Pentoxifylline may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[C09XA02, aliskiren, Pentoxifylline may increase the hypotensive activities of Aliskiren.]
[L01XA03, oxaliplatin, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Oxaliplatin.]
[M01AE12, oxaprozin, The risk or severity of bleeding can be increased when Oxaprozin is combined with Pentoxifylline.]
[N03AF02, oxcarbazepine, Oxcarbazepine may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[A08AA04, dexfenfluramine, The metabolism of Dexfenfluramine can be decreased when combined with Pentoxifylline.]
[L04AB04, adalimumab, The serum concentration of Pentoxifylline can be decreased when it is combined with Adalimumab.]
[N06BA02, dextroamphetamine, The risk or severity of adverse effects can be increased when Amphetamine is combined with Pentoxifylline.]
[N03AC01, paramethadione, Paramethadione may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AB05, paroxetine, The risk or severity of hemorrhage can be increased when Paroxetine is combined with Pentoxifylline.]
[B01AC04, clopidogrel, Pentoxifylline may increase the antiplatelet activities of Clopidogrel.]
[C01DA05, pentaerythritol tetranitrate, Pentoxifylline may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[C04AD01, pentifylline, The serum concentration of Pentifylline can be increased when it is combined with Pentoxifylline.]
[P03AC04, permethrin, Pentoxifylline may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, The therapeutic efficacy of Diazepam can be decreased when used in combination with Pentoxifylline.]
[N03AX07, phenacemide, Phenacemide may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AH01, diazoxide, Pentoxifylline may increase the hypotensive activities of Diazoxide.]
[N03AD02, phensuximide, Phensuximide may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[R05DA08, pholcodine, Pentoxifylline may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, The risk or severity of bleeding can be increased when Diclofenac is combined with Pentoxifylline.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[A03AA07, dicyclomine, Dicyclomine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J05AF02, didanosine, Pentoxifylline may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[C02DG01, pinacidil, Pentoxifylline may increase the hypotensive activities of Pinacidil.]
[L01DC04, ixabepilone, The metabolism of Pentoxifylline can be decreased when combined with Ixabepilone.]
[L01EB02, erlotinib, The metabolism of Pentoxifylline can be decreased when combined with Erlotinib.]
[R03CC07, pirbuterol, The risk or severity of hypokalemia can be increased when Pentoxifylline is combined with Pirbuterol.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[A08AA03, diethylpropion, The risk or severity of adverse effects can be increased when Diethylpropion is combined with Pentoxifylline.]
[C08CA03, isradipine, Pentoxifylline may increase the hypotensive activities of Isradipine.]
[D07XC04, diflucortolone, Pentoxifylline may decrease the excretion rate of Difluocortolone which could result in a higher serum level.]
[N02BA11, diflunisal, The risk or severity of bleeding can be increased when Diflunisal is combined with Pentoxifylline.]
[C01AA05, digoxin, Pentoxifylline may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C02DB01, dihydralazine, Pentoxifylline may increase the hypotensive activities of Dihydralazine.]
[N02AA03, hydromorphone, Hydromorphone may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[L04AX04, lenalidomide, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Lenalidomide.]
[J05AE08, atazanavir, The metabolism of Pentoxifylline can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, Pentoxifylline may increase the hypotensive activities of Treprostinil.]
[H03BC01, potassium perchlorate, Potassium perchlorate may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[V03AB04, pralidoxime, Pralidoxime may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[C08DB01, diltiazem, Pentoxifylline may increase the hypotensive activities of Diltiazem.]
[V03AB09, dimercaprol, Pentoxifylline may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[R03CC08, procaterol, The risk or severity of adverse effects can be increased when Procaterol is combined with Pentoxifylline.]
[M02AX03, dimethyl sulfoxide, Pentoxifylline may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.]
[N03AG05, progabide, Progabide may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BC02, propentofylline, The serum concentration of Propentofylline can be increased when it is combined with Pentoxifylline.]
[N02BB04, propyphenazone, The risk or severity of bleeding can be increased when Propyphenazone is combined with Pentoxifylline.]
[M01AB14, proglumetacin, The risk or severity of bleeding can be increased when Proglumetacin is combined with Pentoxifylline.]
[R03DA03, proxyphylline, The serum concentration of Proxyphylline can be increased when it is combined with Pentoxifylline.]
[N05CD10, quazepam, The therapeutic efficacy of Quazepam can be decreased when used in combination with Pentoxifylline.]
[C09AA06, quinapril, Pentoxifylline may increase the hypotensive activities of Quinapril.]
[B01AC07, dipyridamole, The therapeutic efficacy of Dipyridamole can be increased when used in combination with Pentoxifylline.]
[B01AD10, drotrecogin alfa, The therapeutic efficacy of Drotrecogin alfa can be increased when used in combination with Pentoxifylline.]
[C09AA05, ramipril, Pentoxifylline may increase the hypotensive activities of Ramipril.]
[S01XA23, sirolimus, The metabolism of Pentoxifylline can be decreased when combined with Sirolimus.]
[S01AX06, resorcinol, Pentoxifylline may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, The metabolism of Pentoxifylline can be decreased when combined with Disopyramide.]
[P03AA04, disulfiram, The serum concentration of Pentoxifylline can be increased when it is combined with Disulfiram.]
[S02AA12, rifamycin SV, The metabolism of Pentoxifylline can be decreased when combined with Rifamycin.]
[N07XX02, riluzole, Riluzole may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AE09, levocetirizine, Pentoxifylline may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[N01BB09, ropivacaine, The metabolism of Pentoxifylline can be decreased when combined with Ropivacaine.]
[J01MB01, rosoxacin, The metabolism of Pentoxifylline can be decreased when combined with Rosoxacin.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XG01, bortezomib, The metabolism of Pentoxifylline can be decreased when combined with Bortezomib.]
[G04BE08, tadalafil, Pentoxifylline may increase the hypotensive activities of Tadalafil.]
[S01BC05, ketorolac, The risk or severity of bleeding can be increased when Ketorolac is combined with Pentoxifylline.]
[C02KX02, ambrisentan, Pentoxifylline may increase the hypotensive activities of Ambrisentan.]
[C01EB18, ranolazine, Ranolazine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N02BA06, salsalate, The risk or severity of bleeding can be increased when Salsalate is combined with Pentoxifylline.]
[R03AC12, salmeterol, The risk or severity of hypokalemia can be increased when Pentoxifylline is combined with Salmeterol.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[C01CA07, dobutamine, The risk or severity of adverse effects can be increased when Dobutamine is combined with Pentoxifylline.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Pentoxifylline.]
[C01CA04, dopamine, The risk or severity of adverse effects can be increased when Dopamine is combined with Pentoxifylline.]
[N06AA16, dothiepin, The metabolism of Pentoxifylline can be decreased when combined with Dosulepin.]
[N06AA12, doxepin, The metabolism of Doxepin can be decreased when combined with Pentoxifylline.]
[L01DB01, doxorubicin, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Doxorubicin.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N06AB06, sertraline, The risk or severity of bleeding can be increased when Sertraline is combined with Pentoxifylline.]
[A08AA10, sibutramine, The risk or severity of hemorrhage can be increased when Sibutramine is combined with Pentoxifylline.]
[A12CA02, sodium sulfate, Pentoxifylline may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[C09AA11, spirapril, Pentoxifylline may increase the hypotensive activities of Spirapril.]
[R03DA01, dyphylline, The serum concentration of Dyphylline can be increased when it is combined with Pentoxifylline.]
[N02CC01, sumatriptan, Sumatriptan may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[V04CX07, edrophonium, Pentoxifylline may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[C07AB13, talinolol, Pentoxifylline may increase the hypotensive activities of Talinolol.]
[J01MA05, temafloxacin, The metabolism of Pentoxifylline can be decreased when combined with Temafloxacin.]
[L01AX03, temozolomide, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Temozolomide.]
[M01AC02, tenoxicam, The risk or severity of bleeding can be increased when Tenoxicam is combined with Pentoxifylline.]
[G04CA03, terazosin, Pentoxifylline may increase the hypotensive activities of Terazosin.]
[D01BA02, terbinafine, The metabolism of Terbinafine can be decreased when combined with Pentoxifylline.]
[C07AA16, tertatolol, The risk or severity of adverse effects can be increased when Tertatolol is combined with Pentoxifylline.]
[S01GA02, tetrahydrozoline, The risk or severity of adverse effects can be increased when Tetryzoline is combined with Pentoxifylline.]
[C09AA02, enalapril, Pentoxifylline may increase the hypotensive activities of Enalapril.]
[M01AG02, tolfenamic acid, The risk or severity of bleeding can be increased when Tolfenamic acid is combined with Pentoxifylline.]
[N06AG03, toloxatone, The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Pentoxifylline.]
[N06BA09, atomoxetine, Atomoxetine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N03AX11, topiramate, Topiramate may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[C03CA04, torsemide, Pentoxifylline may increase the hypotensive activities of Torasemide.]
[R01AA09, tramazoline, The risk or severity of adverse effects can be increased when Tramazoline is combined with Pentoxifylline.]
[C09AA10, trandolapril, Pentoxifylline may increase the hypotensive activities of Trandolapril.]
[N05CD11, triazulenone, The therapeutic efficacy of Loprazolam can be decreased when used in combination with Pentoxifylline.]
[N05CC01, chloral hydrate, Pentoxifylline may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[B01AC18, triflusal, The therapeutic efficacy of Triflusal can be increased when used in combination with Pentoxifylline.]
[C05CA04, troxerutin, The therapeutic efficacy of Troxerutin can be increased when used in combination with Pentoxifylline.]
[C02CA06, urapidil, Pentoxifylline may increase the hypotensive activities of Urapidil.]
[J01MA04, enoxacin, The serum concentration of Pentoxifylline can be increased when it is combined with Enoxacin.]
[L01CA04, vinorelbine, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Vinorelbine.]
[S01FB02, ephedrine, The risk or severity of adverse effects can be increased when Ephedrine is combined with Pentoxifylline.]
[N06AX16, venlafaxine, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Venlafaxine.]
[S01EA01, epinephrine, The risk or severity of adverse effects can be increased when Epinephrine is combined with Pentoxifylline.]
[L01DB03, epirubicin, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Epirubicin.]
[C09AA15, zofenopril, Pentoxifylline may increase the hypotensive activities of Zofenopril.]
[N05CF02, zolpidem, The metabolism of Pentoxifylline can be decreased when combined with Zolpidem.]
[M01AB04, zomepirac, The risk or severity of bleeding can be increased when Zomepirac is combined with Pentoxifylline.]
[N03AX15, zonisamide, Zonisamide may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AB06, insulin glulisine, human, The risk or severity of hypoglycemia can be increased when Pentoxifylline is combined with Insulin glulisine.]
[N05AX11, zotepine, The metabolism of Zotepine can be decreased when combined with Pentoxifylline.]
[B01AD03, anistreplase, The therapeutic efficacy of Anistreplase can be increased when used in combination with Pentoxifylline.]
[L01XA02, carboplatin, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Carboplatin.]
[C02AC02, guanfacine, Pentoxifylline may increase the hypotensive activities of Guanfacine.]
[B01AC11, iloprost, Pentoxifylline may increase the antiplatelet activities of Iloprost.]
[N03AG01, valproic acid, Valproic acid may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[L03AX05, pidotimod, Pentoxifylline may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[S01AA17, erythromycin, The metabolism of Pentoxifylline can be decreased when combined with Erythromycin.]
[N05CD04, estazolam, The therapeutic efficacy of Estazolam can be decreased when used in combination with Pentoxifylline.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[H05BX01, cinacalcet, The metabolism of Cinacalcet can be decreased when combined with Pentoxifylline.]
[G03CA03, estradiol, The metabolism of Pentoxifylline can be decreased when combined with Estradiol.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Pentoxifylline can be decreased when combined with Conjugated estrogens.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[C01CA15, gepefrine, The risk or severity of adverse effects can be increased when Gepefrine is combined with Pentoxifylline.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be decreased when combined with Pentoxifylline.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N03AD01, ethosuximide, Ethosuximide may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AB01, ethotoin, Ethotoin may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AC06, meloxicam, The risk or severity of bleeding can be increased when Meloxicam is combined with Pentoxifylline.]
[C01CA01, etilefrine, The risk or severity of adverse effects can be increased when Etilefrine is combined with Pentoxifylline.]
[N01AX07, etomidate, Etomidate may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[L01CB01, etoposide, The metabolism of Pentoxifylline can be decreased when combined with Etoposide.]
[L04AD02, tacrolimus, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Tacrolimus.]
[J01MA08, fleroxacin, The metabolism of Pentoxifylline can be decreased when combined with Fleroxacin.]
[P01AX07, trimetrexate, Pentoxifylline may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, Pentoxifylline may decrease the excretion rate of Bupropion which could result in a higher serum level.]
[N06AB08, fluvoxamine, The metabolism of Pentoxifylline can be decreased when combined with Fluvoxamine.]
[C01BB03, tocainide, The metabolism of Tocainide can be decreased when combined with Pentoxifylline.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, Pentoxifylline may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[A05AA01, chenodeoxycholic acid, The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Chenodeoxycholic acid.]
[D11AX24, deoxycholic acid, The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Deoxycholic acid.]
[B05AA05, dextran, The therapeutic efficacy of Dextran can be increased when used in combination with Pentoxifylline.]
[V03AF02, dexrazoxane, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Dexrazoxane.]
[A02BA03, famotidine, The metabolism of Pentoxifylline can be decreased when combined with Famotidine.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[P02CA03, albendazole, The metabolism of Pentoxifylline can be increased when combined with Albendazole.]
[C08CA02, felodipine, Pentoxifylline may increase the hypotensive activities of Felodipine.]
[N03AX26, fenfluramine, Fenfluramine may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AE04, fenoprofen, The risk or severity of bleeding can be increased when Fenoprofen is combined with Pentoxifylline.]
[R03CC04, fenoterol, The risk or severity of adverse effects can be increased when Fenoterol is combined with Pentoxifylline.]
[N02AB03, fentanyl, Pentoxifylline may decrease the excretion rate of Fentanyl which could result in a higher serum level.]
[R03CC02, albuterol, Pentoxifylline may decrease the excretion rate of Salbutamol which could result in a higher serum level.]
[L03AB02, interferon-beta, The metabolism of Pentoxifylline can be decreased when combined with Human interferon beta.]
[B01AD05, plasmin, The therapeutic efficacy of Fibrinolysin can be increased when used in combination with Pentoxifylline.]
[L01BB06, clofarabine, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Clofarabine.]
[L04AA40, cladribine, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Cladribine.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[G04BD02, flavoxate, Pentoxifylline may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Pentoxifylline.]
[N02BG04, floctafenine, The risk or severity of bleeding can be increased when Floctafenine is combined with Pentoxifylline.]
[J02AC01, fluconazole, Fluconazole may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J02AX01, flucytosine, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Flucytosine.]
[V03AB25, flumazenil, Pentoxifylline may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[N07CA03, flunarizine, Flunarizine may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD03, flunitrazepam, The therapeutic efficacy of Flunitrazepam can be decreased when used in combination with Pentoxifylline.]
[V03AZ01, ethanol, The metabolism of Ethanol can be decreased when combined with Pentoxifylline.]
[L01BC09, floxuridine, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Floxuridine.]
[L01BC02, fluorouracil, The metabolism of Pentoxifylline can be decreased when combined with Fluorouracil.]
[N06AB03, fluoxetine, The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Pentoxifylline.]
[N05CD01, flurazepam, The therapeutic efficacy of Flurazepam can be decreased when used in combination with Pentoxifylline.]
[S01BC04, flurbiprofen, The risk or severity of bleeding can be increased when Flurbiprofen is combined with Pentoxifylline.]
[L02BB01, flutamide, The metabolism of Pentoxifylline can be decreased when combined with Flutamide.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[S02AA17, fosfomycin, Pentoxifylline may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Pentoxifylline.]
[G01AX06, furazolidone, The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Pentoxifylline.]
[C03CA01, furosemide, Pentoxifylline may increase the hypotensive activities of Furosemide.]
[N05CF04, eszopiclone, Eszopiclone may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[S01AD09, ganciclovir, Pentoxifylline may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N03AA04, barbexaclone, The serum concentration of Pentoxifylline can be decreased when it is combined with Barbexaclone.]
[C10AB04, gemfibrozil, The metabolism of Pentoxifylline can be decreased when combined with Gemfibrozil.]
[J01XA03, telavancin, Pentoxifylline may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EA02, dasatinib, Dasatinib may increase the anticoagulant activities of Pentoxifylline.]
[C01CA21, cafedrine, The serum concentration of Cafedrine can be increased when it is combined with Pentoxifylline.]
[N03AD03, methsuximide, Methsuximide may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BB07, glipizide, Pentoxifylline may decrease the excretion rate of Glipizide which could result in a higher serum level.]
[M01AX05, glucosamine, Glucosamine may increase the antiplatelet activities of Pentoxifylline.]
[N05CM18, dexmedetomidine, The metabolism of Pentoxifylline can be decreased when combined with Dexmedetomidine.]
[C05AE01, nitroglycerin, Pentoxifylline may increase the hypotensive activities of Nitroglycerin.]
[C02CA04, doxazosin, Pentoxifylline may increase the hypotensive activities of Doxazosin.]
[H01AB01, thyrotropin alfa, Thyrotropin alfa may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[L01EX02, sorafenib, The metabolism of Pentoxifylline can be decreased when combined with Sorafenib.]
[C07AB09, esmolol, Pentoxifylline may increase the hypotensive activities of Esmolol.]
[M01CB04, aurothioglucose, Pentoxifylline may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Pentoxifylline may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[B01AA12, fluindione, The therapeutic efficacy of Fluindione can be increased when used in combination with Pentoxifylline.]
[C09AA09, fosinopril, Pentoxifylline may increase the hypotensive activities of Fosinopril.]
[S01EX01, guanethidine, Pentoxifylline may increase the hypotensive activities of Guanethidine.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N05AD01, haloperidol, The metabolism of Pentoxifylline can be decreased when combined with Haloperidol.]
[N05AH04, quetiapine, Pentoxifylline may decrease the excretion rate of Quetiapine which could result in a higher serum level.]
[N06BX13, idebenone, Pentoxifylline may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[A10AD05, insulin aspart, human, The risk or severity of hypoglycemia can be increased when Pentoxifylline is combined with Insulin aspart.]
[L01CE02, irinotecan, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Irinotecan.]
[M04AA01, allopurinol, The serum concentration of Pentoxifylline can be increased when it is combined with Allopurinol.]
[C09CA01, losartan, Pentoxifylline may increase the hypotensive activities of Losartan.]
[S01XA14, heparin, The therapeutic efficacy of Heparin can be increased when used in combination with Pentoxifylline.]
[G03DC01, allylestrenol, Pentoxifylline may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, The risk or severity of bleeding can be increased when Mesalazine is combined with Pentoxifylline.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[L01XX03, altretamine, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Altretamine.]
[N05CA16, hexobarbital, The serum concentration of Pentoxifylline can be decreased when it is combined with Hexobarbital.]
[R03CC05, hexoprenaline, The risk or severity of hypokalemia can be increased when Pentoxifylline is combined with Hexoprenaline.]
[J05AG01, nevirapine, The metabolism of Pentoxifylline can be decreased when combined with Nevirapine.]
[C08CA10, nilvadipine, Pentoxifylline may increase the hypotensive activities of Nilvadipine.]
[M02AA26, nimesulide, Pentoxifylline may increase the antiplatelet activities of Nimesulide.]
[C09AA04, perindopril, Pentoxifylline may increase the hypotensive activities of Perindopril.]
[C02DB02, hydralazine, Pentoxifylline may increase the hypotensive activities of Hydralazine.]
[C03AA03, hydrochlorothiazide, Pentoxifylline may increase the hypotensive activities of Hydrochlorothiazide.]
[C03AA02, hydroflumethiazide, Pentoxifylline may increase the hypotensive activities of Hydroflumethiazide.]
[B05XA17, potassium acetate, Pentoxifylline may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[G04BD06, propiverine, Pentoxifylline may decrease the excretion rate of Propiverine which could result in a higher serum level.]
[B05AA07, hetastarch, Pentoxifylline may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[L01XX05, hydroxyurea, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Hydroxyurea.]
[C02AC06, rilmenidine, Pentoxifylline may increase the hypotensive activities of Rilmenidine.]
[R02AX02, ibuprofen, The risk or severity of bleeding can be increased when Ibuprofen is combined with Pentoxifylline.]
[B05XA08, sodium acetate, Pentoxifylline may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[B05CB02, sodium citrate, The therapeutic efficacy of Sodium citrate can be increased when used in combination with Pentoxifylline.]
[L01DB06, idarubicin, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Idarubicin.]
[L01AA06, ifosfamide, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Ifosfamide.]
[H01AC02, somatrem, The metabolism of Pentoxifylline can be increased when combined with Somatrem.]
[N06AA02, imipramine, The metabolism of Pentoxifylline can be decreased when combined with Imipramine.]
[L01CD01, paclitaxel, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Paclitaxel.]
[R01AD07, tixocortol, Pentoxifylline may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[M03BX02, tizanidine, Tizanidine may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[L01CE01, topotecan, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Topotecan.]
[C03BA11, indapamide, Pentoxifylline may increase the hypotensive activities of Indapamide.]
[S01BC01, indomethacin, The risk or severity of bleeding can be increased when Indomethacin is combined with Pentoxifylline.]
[C02CA02, indoramin, Pentoxifylline may increase the hypotensive activities of Indoramin.]
[A11HA07, inositol, Pentoxifylline may decrease the excretion rate of Inositol which could result in a higher serum level.]
[L03AB04, interferon alfa-2a, The metabolism of Pentoxifylline can be decreased when combined with Interferon alfa-2a.]
[L03AB05, interferon alfa-2b, The metabolism of Pentoxifylline can be decreased when combined with Interferon alfa-2b.]
[N06AX17, milnacipran, The risk or severity of hemorrhage can be increased when Milnacipran is combined with Pentoxifylline.]
[S01XA28, varenicline, Pentoxifylline may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[A10BH01, sitagliptin, Pentoxifylline may decrease the excretion rate of Sitagliptin which could result in a higher serum level.]
[N05BA12, alprazolam, The therapeutic efficacy of Alprazolam can be decreased when used in combination with Pentoxifylline.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be decreased when combined with Pentoxifylline.]
[L01XX35, anagrelide, Pentoxifylline may increase the antiplatelet activities of Anagrelide.]
[C07AA01, alprenolol, Pentoxifylline may increase the hypotensive activities of Alprenolol.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[L03AB09, interferon alfacon-1, The metabolism of Pentoxifylline can be decreased when combined with Interferon alfacon-1.]
[V03AB01, ipecac, Pentoxifylline may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[N06AF05, iproniazid, The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Pentoxifylline.]
[J05AB13, penciclovir, The metabolism of Pentoxifylline can be decreased when combined with Penciclovir.]
[N06AF01, isocarboxazid, The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Pentoxifylline.]
[R03CC06, isoetharine, The risk or severity of hypokalemia can be increased when Pentoxifylline is combined with Isoetharine.]
[C09AA16, imidapril, Pentoxifylline may increase the hypotensive activities of Imidapril.]
[J04AC01, isoniazid, The serum concentration of Pentoxifylline can be increased when it is combined with Isoniazid.]
[J05AX05, inosine pranobex, Pentoxifylline may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[R03CB01, isoproterenol, The serum concentration of Pentoxifylline can be decreased when it is combined with Isoprenaline.]
[C01DA14, isosorbide mononitrate, Pentoxifylline may increase the vasodilatory activities of Isosorbide mononitrate.]
[D10BA01, isotretinoin, Pentoxifylline may decrease the excretion rate of Isotretinoin which could result in a higher serum level.]
[C04AA01, isoxsuprine, The risk or severity of adverse effects can be increased when Isoxsuprine is combined with Pentoxifylline.]
[B01AE06, bivalirudin, The therapeutic efficacy of Bivalirudin can be increased when used in combination with Pentoxifylline.]
[J01FA07, josamycin, The metabolism of Pentoxifylline can be decreased when combined with Josamycin.]
[S01AA24, kanamycin, Pentoxifylline may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[H01AC01, somatropin, The metabolism of Pentoxifylline can be increased when combined with Somatotropin.]
[L04AC07, tocilizumab, The metabolism of Pentoxifylline can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, Pentoxifylline may decrease the excretion rate of Ketamine which could result in a higher serum level.]
[C02KD01, ketanserin, Pentoxifylline may increase the hypotensive activities of Ketanserin.]
[B01AC22, prasugrel, The therapeutic efficacy of Prasugrel can be increased when used in combination with Pentoxifylline.]
[J02AB02, ketoconazole, The metabolism of Pentoxifylline can be decreased when combined with Ketoconazole.]
[N05AH03, olanzapine, The metabolism of Pentoxifylline can be decreased when combined with Olanzapine.]
[M02AA10, ketoprofen, The risk or severity of bleeding can be increased when Ketoprofen is combined with Pentoxifylline.]
[V03AC03, deferasirox, The serum concentration of Pentoxifylline can be increased when it is combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Pentoxifylline can be increased when combined with Abatacept.]
[C01CA22, arbutamine, The risk or severity of hypokalemia can be increased when Pentoxifylline is combined with Arbutamine.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01MB02, nalidixic acid, The metabolism of Pentoxifylline can be decreased when combined with Nalidixic acid.]
[M01AE11, tiaprofenic acid, The risk or severity of bleeding can be increased when Tiaprofenic acid is combined with Pentoxifylline.]
[C07AG01, labetalol, Pentoxifylline may increase the hypotensive activities of Labetalol.]
[N04BB01, amantadine, Pentoxifylline may decrease the excretion rate of Amantadine which could result in a higher serum level.]
[C02AA05, deserpidine, Pentoxifylline may increase the hypotensive activities of Deserpidine.]
[A06AX03, lubiprostone, Pentoxifylline may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[N03AX18, lacosamide, Lacosamide may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[A05AA02, ursodiol, The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Ursodeoxycholic acid.]
[L01DC03, mitomycin, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Mitomycin.]
[S02DA01, lidocaine, The metabolism of Pentoxifylline can be decreased when combined with Lidocaine.]
[C01EB21, regadenoson, Pentoxifylline may decrease effectiveness of Regadenoson as a diagnostic agent.]
[S01AA21, amikacin, Pentoxifylline may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[N06BA13, armodafinil, The metabolism of Pentoxifylline can be increased when combined with Armodafinil.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[L01AD02, lomustine, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Lomustine.]
[N05BA06, lorazepam, The therapeutic efficacy of Lorazepam can be decreased when used in combination with Pentoxifylline.]
[L01EG01, temsirolimus, The metabolism of Pentoxifylline can be decreased when combined with Temsirolimus.]
[B05XA11, magnesium chloride, Pentoxifylline may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Pentoxifylline may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[V04CC02, magnesium sulfate, Magnesium sulfate may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BA05, pralatrexate, Pentoxifylline may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Nilotinib.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, The metabolism of Maprotiline can be decreased when combined with Pentoxifylline.]
[C02BB01, mecamylamine, Pentoxifylline may increase the hypotensive activities of Mecamylamine.]
[L01AA05, mechlorethamine, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Mechlorethamine.]
[M02AA18, meclofenamic acid, The risk or severity of bleeding can be increased when Meclofenamic acid is combined with Pentoxifylline.]
[N05BA03, medazepam, The therapeutic efficacy of Medazepam can be decreased when used in combination with Pentoxifylline.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AB06, nadroparin, The therapeutic efficacy of Nadroparin can be increased when used in combination with Pentoxifylline.]
[B01AB05, enoxaparin, The therapeutic efficacy of Enoxaparin can be increased when used in combination with Pentoxifylline.]
[B01AB04, dalteparin, The therapeutic efficacy of Dalteparin can be increased when used in combination with Pentoxifylline.]
[N05CH01, melatonin, The metabolism of Melatonin can be decreased when combined with Pentoxifylline.]
[L01AA03, melphalan, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Melphalan.]
[N06DX01, memantine, Pentoxifylline may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, Meperidine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[C01CA11, mephentermine, The risk or severity of adverse effects can be increased when Mephentermine is combined with Pentoxifylline.]
[N03AB04, mephenytoin, Mephenytoin may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AA01, mephobarbital, The serum concentration of Pentoxifylline can be decreased when it is combined with Methylphenobarbital.]
[N01BB03, mepivacaine, Pentoxifylline may decrease the excretion rate of Mepivacaine which could result in a higher serum level.]
[G04BX16, tiopronin, Pentoxifylline may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, Pentoxifylline may decrease the excretion rate of Paliperidone which could result in a higher serum level.]
[C01CA09, metaraminol, The risk or severity of adverse effects can be increased when Metaraminol is combined with Pentoxifylline.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N07BC02, methadone, Methadone may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N06BA03, methamphetamine, The risk or severity of adverse effects can be increased when Metamfetamine is combined with Pentoxifylline.]
[J05AF05, lamivudine, Lamivudine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N03AA30, metharbital, Metharbital may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, Methimazole may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[L01BA04, pemetrexed, Pentoxifylline may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[N05CA15, methohexital, The serum concentration of Pentoxifylline can be decreased when it is combined with Methohexital.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[L04AX03, methotrexate, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Methotrexate.]
[C01CA10, methoxamine, The risk or severity of adverse effects can be increased when Methoxamine is combined with Pentoxifylline.]
[D05BA02, methoxsalen, The metabolism of Pentoxifylline can be decreased when combined with Methoxsalen.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, Pentoxifylline may increase the hypotensive activities of Methyldopa.]
[V04CG05, methylene blue, The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Pentoxifylline.]
[R03DA05, aminophylline, The serum concentration of Aminophylline can be increased when it is combined with Pentoxifylline.]
[N03AF03, rufinamide, Rufinamide may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[G03EK01, methyltestosterone, Pentoxifylline may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[A03FA01, metoclopramide, The metabolism of Metoclopramide can be decreased when combined with Pentoxifylline.]
[C03BA08, metolazone, Pentoxifylline may increase the hypotensive activities of Metolazone.]
[C07AB02, metoprolol, Pentoxifylline may increase the hypotensive activities of Metoprolol.]
[V04CD01, metyrapone, Pentoxifylline may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[C01BB02, mexiletine, The metabolism of Pentoxifylline can be decreased when combined with Mexiletine.]
[N06AX03, mianserin, The metabolism of Mianserin can be decreased when combined with Pentoxifylline.]
[N02BB03, aminopyrine, The risk or severity of bleeding can be increased when Aminophenazone is combined with Pentoxifylline.]
[B01AB07, parnaparin, The therapeutic efficacy of Parnaparin can be increased when used in combination with Pentoxifylline.]
[N05CD08, midazolam, The therapeutic efficacy of Midazolam can be decreased when used in combination with Pentoxifylline.]
[C01CA17, midodrine, The risk or severity of adverse effects can be increased when Midodrine is combined with Pentoxifylline.]
[B01AB10, tinzaparin, The therapeutic efficacy of Tinzaparin can be increased when used in combination with Pentoxifylline.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[C09CA03, valsartan, Pentoxifylline may increase the hypotensive activities of Valsartan.]
[D11AX01, minoxidil, Pentoxifylline may increase the hypotensive activities of Minoxidil.]
[J01FA11, miocamycin, The metabolism of Pentoxifylline can be decreased when combined with Miocamycin.]
[L01DB07, mitoxantrone, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Mitoxantrone.]
[N06BA12, lisdexamfetamine, The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with Pentoxifylline.]
[L03AC01, aldesleukin, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Aldesleukin.]
[C01BD01, amiodarone, The serum concentration of Pentoxifylline can be increased when it is combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Pentoxifylline can be decreased when combined with Amitriptyline.]
[A04AA05, palonosetron, Palonosetron may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[L04AB05, certolizumab pegol, The metabolism of Pentoxifylline can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Eltrombopag can be decreased when combined with Pentoxifylline.]
[G04BA01, ammonium chloride, Pentoxifylline may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Pentoxifylline.]
[L04AA06, mycophenolic acid, Pentoxifylline may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[N05CA02, amobarbital, The serum concentration of Pentoxifylline can be decreased when it is combined with Amobarbital.]
[N03AB05, fosphenytoin, The serum concentration of Pentoxifylline can be decreased when it is combined with Fosphenytoin.]
[L03AB08, interferon beta-1b, The metabolism of Pentoxifylline can be decreased when combined with Interferon beta-1b.]
[C07AA12, nadolol, Pentoxifylline may increase the hypotensive activities of Nadolol.]
[J01CA04, amoxicillin, Pentoxifylline may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[J01CF06, nafcillin, The metabolism of Pentoxifylline can be increased when combined with Nafcillin.]
[V03AB15, naloxone, Pentoxifylline may decrease the excretion rate of Naloxone which could result in a higher serum level.]
[L04AC03, anakinra, The metabolism of Pentoxifylline can be increased when combined with Anakinra.]
[S01GA01, naphazoline, The risk or severity of adverse effects can be increased when Naphazoline is combined with Pentoxifylline.]
[N06BA01, amphetamine, The risk or severity of adverse effects can be increased when Amphetamine is combined with Pentoxifylline.]
[M02AA12, naproxen, The risk or severity of bleeding can be increased when Naproxen is combined with Pentoxifylline.]
[N06AX21, duloxetine, The risk or severity of hemorrhage can be increased when Duloxetine is combined with Pentoxifylline.]
[N04BX01, tolcapone, Tolcapone may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[L01CD02, docetaxel, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Docetaxel.]
[S03AA01, neomycin, Pentoxifylline may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B01AC17, tirofiban, Pentoxifylline may increase the antiplatelet activities of Tirofiban.]
[J02AA01, amphotericin B, Amphotericin B may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[L03AX16, plerixafor, Pentoxifylline may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Pentoxifylline may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Pentoxifylline.]
[C09CA07, telmisartan, Pentoxifylline may increase the hypotensive activities of Telmisartan.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[M04AA03, febuxostat, The serum concentration of the active metabolites of Pentoxifylline can be increased when Pentoxifylline is used in combination with Febuxostat.]
[C01CE01, inamrinone, Pentoxifylline may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[L01XX01, amsacrine, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Amsacrine.]
[N06AF02, nialamide, The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Pentoxifylline.]
[C08CA04, nicardipine, Pentoxifylline may increase the hypotensive activities of Nicardipine.]
[P02DA01, niclosamide, The metabolism of Pentoxifylline can be decreased when combined with Niclosamide.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Pentoxifylline.]
[M02AA17, niflumic acid, The risk or severity of bleeding can be increased when Niflumic acid is combined with Pentoxifylline.]
[C08CA06, nimodipine, Pentoxifylline may increase the hypotensive activities of Nimodipine.]
[C08CA07, nisoldipine, Pentoxifylline may increase the hypotensive activities of Nisoldipine.]
[N05CD02, nitrazepam, The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Pentoxifylline.]
[C08CA08, nitrendipine, Pentoxifylline may increase the hypotensive activities of Nitrendipine.]
[R07AX01, nitric oxide, Nitric Oxide may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Nitrofurantoin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N05CF03, zaleplon, Zaleplon may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N04BC05, pramipexole, Pramipexole may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[C02DD01, nitroprusside, Pentoxifylline may increase the hypotensive activities of Nitroprusside.]
[C01CA03, norepinephrine, The risk or severity of adverse effects can be increased when Norepinephrine is combined with Pentoxifylline.]
[S01AE02, norfloxacin, The metabolism of Pentoxifylline can be decreased when combined with Norfloxacin.]
[C02KX01, bosentan, Pentoxifylline may increase the hypotensive activities of Bosentan.]
[B01AC16, eptifibatide, Pentoxifylline may increase the antiplatelet activities of Eptifibatide.]
[L03AB07, interferon beta-1a, The metabolism of Pentoxifylline can be decreased when combined with Interferon beta-1a.]
[G02CA02, nylidrin, The risk or severity of adverse effects can be increased when Nylidrin is combined with Pentoxifylline.]
[B01AB08, reviparin, The therapeutic efficacy of Reviparin can be increased when used in combination with Pentoxifylline.]
[S02AA16, ofloxacin, The metabolism of Pentoxifylline can be decreased when combined with Ofloxacin.]
[J01FA05, oleandomycin, The metabolism of Pentoxifylline can be decreased when combined with Oleandomycin.]
[L04AC04, rilonacept, The metabolism of Pentoxifylline can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Pentoxifylline can be increased when combined with Omeprazole.]
[N02AA02, opium, Pentoxifylline may decrease the excretion rate of Opium which could result in a higher serum level.]
[R03CB03, metaproterenol, The risk or severity of adverse effects can be increased when Orciprenaline is combined with Pentoxifylline.]
[B01AD07, reteplase, The therapeutic efficacy of Reteplase can be increased when used in combination with Pentoxifylline.]
[B01AD09, ancrod, The therapeutic efficacy of Ancrod can be increased when used in combination with Pentoxifylline.]
[G04CA02, tamsulosin, Tamsulosin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01CF04, oxacillin, Oxacillin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N05BA04, oxazepam, The therapeutic efficacy of Oxazepam can be decreased when used in combination with Pentoxifylline.]
[J01MB05, oxolinic acid, The metabolism of Pentoxifylline can be decreased when combined with Oxolinic acid.]
[C07AA02, oxprenolol, Pentoxifylline may increase the hypotensive activities of Oxprenolol.]
[S01GA04, oxymetazoline, The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Pentoxifylline.]
[S01BC02, oxyphenbutazone, The risk or severity of bleeding can be increased when Oxyphenbutazone is combined with Pentoxifylline.]
[J04AA01, aminosalicylic acid, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Aminosalicylic acid.]
[N05AH05, asenapine, The metabolism of Asenapine can be decreased when combined with Pentoxifylline.]
[B01AB09, danaparoid, The therapeutic efficacy of Danaparoid can be increased when used in combination with Pentoxifylline.]
[M03AC01, pancuronium, The therapeutic efficacy of Pancuronium can be decreased when used in combination with Pentoxifylline.]
[J04AB30, capreomycin, Pentoxifylline may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[N05CC05, paraldehyde, Paraldehyde may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[C02KC01, pargyline, Pentoxifylline may increase the hypotensive activities of Pargyline.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01MA03, pefloxacin, The metabolism of Pentoxifylline can be decreased when combined with Pefloxacin.]
[G04BD11, fesoterodine, Pentoxifylline may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, Pentoxifylline may increase the hypotensive activities of Penbutolol.]
[M01CC01, penicillamine, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Penicillamine.]
[J01CE09, penicillin G procaine, Pentoxifylline may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, The serum concentration of Pentoxifylline can be decreased when it is combined with Pentobarbital.]
[L01XX08, pentostatin, Pentoxifylline may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[J01MB04, pipemidic acid, The metabolism of Pentoxifylline can be decreased when combined with Pipemidic acid.]
[N05AB03, perphenazine, The metabolism of Perphenazine can be decreased when combined with Pentoxifylline.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Pentoxifylline.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N06AF03, phenelzine, The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Pentoxifylline.]
[B01AA02, phenindione, The therapeutic efficacy of Phenindione can be increased when used in combination with Pentoxifylline.]
[N03AA02, phenobarbital, The serum concentration of Pentoxifylline can be decreased when it is combined with Phenobarbital.]
[C04AX02, phenoxybenzamine, Pentoxifylline may increase the hypotensive activities of Phenoxybenzamine.]
[B01AA04, phenprocoumon, The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Pentoxifylline.]
[A08AA01, phentermine, The risk or severity of adverse effects can be increased when Phentermine is combined with Pentoxifylline.]
[V03AB36, phentolamine, Pentoxifylline may increase the hypotensive activities of Phentolamine.]
[M02AA01, phenylbutazone, The risk or severity of bleeding can be increased when Phenylbutazone is combined with Pentoxifylline.]
[S01GA05, phenylephrine, The risk or severity of adverse effects can be increased when Phenylephrine is combined with Pentoxifylline.]
[R01BA01, phenylpropanolamine, The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Pentoxifylline.]
[N03AB02, phenytoin, The serum concentration of Pentoxifylline can be decreased when it is combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Pentoxifylline can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, The metabolism of Pentoxifylline can be decreased when combined with Levofloxacin.]
[B02BA01, vitamin K1, Pentoxifylline may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[C08CX01, mibefradil, Pentoxifylline may increase the hypotensive activities of Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Pentoxifylline.]
[C07AA03, pindolol, Pentoxifylline may increase the hypotensive activities of Pindolol.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N06BX03, piracetam, Pentoxifylline may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[C09CA02, eprosartan, Pentoxifylline may increase the hypotensive activities of Eprosartan.]
[S01BC06, piroxicam, The risk or severity of bleeding can be increased when Piroxicam is combined with Pentoxifylline.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[J01MA11, grepafloxacin, The metabolism of Pentoxifylline can be decreased when combined with Grepafloxacin.]
[C09CA04, irbesartan, Pentoxifylline may increase the hypotensive activities of Irbesartan.]
[B01AC13, abciximab, The therapeutic efficacy of Abciximab can be increased when used in combination with Pentoxifylline.]
[S01XA13, alteplase, The therapeutic efficacy of Alteplase can be increased when used in combination with Pentoxifylline.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[A03AE01, alosetron, The metabolism of Pentoxifylline can be decreased when combined with Alosetron.]
[L04AC08, canakinumab, The metabolism of Pentoxifylline can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, Pentoxifylline may increase the hypotensive activities of Polythiazide.]
[J05AE03, ritonavir, The metabolism of Pentoxifylline can be increased when combined with Ritonavir.]
[A10BH03, saxagliptin, Pentoxifylline may decrease the excretion rate of Saxagliptin which could result in a higher serum level.]
[B05XA01, potassium chloride, Potassium chloride may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[V03AB21, potassium iodide, Potassium Iodide may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[A10AD04, insulin lispro, The risk or severity of hypoglycemia can be increased when Pentoxifylline is combined with Insulin lispro.]
[C07AB01, practolol, Pentoxifylline may increase the hypotensive activities of Practolol.]
[N05BA11, prazepam, The therapeutic efficacy of Prazepam can be decreased when used in combination with Pentoxifylline.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Pentoxifylline.]
[C02CA01, prazosin, Pentoxifylline may increase the hypotensive activities of Prazosin.]
[H02AB07, prednisone, Prednisone may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[P01BA03, primaquine, The metabolism of Pentoxifylline can be increased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Pentoxifylline can be increased when combined with Primidone.]
[M04AB01, probenecid, The serum concentration of Pentoxifylline can be increased when it is combined with Probenecid.]
[C01BA02, procainamide, Pentoxifylline may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[S01HA05, procaine, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Pentoxifylline.]
[L01XB01, procarbazine, The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Pentoxifylline.]
[C10AB05, fenofibrate, Pentoxifylline may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N05AA03, promazine, The metabolism of Pentoxifylline can be decreased when combined with Promazine.]
[R06AD02, promethazine, Pentoxifylline may decrease the excretion rate of Promethazine which could result in a higher serum level.]
[C01BC03, propafenone, The serum concentration of Pentoxifylline can be increased when it is combined with Propafenone.]
[A03AB05, propantheline, Propantheline may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[C07AA05, propranolol, Pentoxifylline may increase the hypotensive activities of Propranolol.]
[H03BA02, propylthiouracil, Propylthiouracil may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N02CC04, rizatriptan, Pentoxifylline may decrease the excretion rate of Rizatriptan which could result in a higher serum level.]
[B01AC09, epoprostenol, The therapeutic efficacy of Epoprostenol can be increased when used in combination with Pentoxifylline.]
[R01BA02, pseudoephedrine, The risk or severity of adverse effects can be increased when Pseudoephedrine is combined with Pentoxifylline.]
[N07XX07, dalfampridine, Pentoxifylline may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Pentoxifylline may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[C01BA01, quinidine, The serum concentration of Pentoxifylline can be increased when it is combined with Quinidine.]
[P01BC01, quinine, The serum concentration of Pentoxifylline can be increased when it is combined with Quinine.]
[A02BA02, ranitidine, The metabolism of Ranitidine can be decreased when combined with Pentoxifylline.]
[C02AA01, rescinnamine, Pentoxifylline may increase the hypotensive activities of Rescinnamine.]
[C02AA02, reserpine, Pentoxifylline may increase the hypotensive activities of Reserpine.]
[J05AP01, ribavirin, Pentoxifylline may decrease the excretion rate of Ribavirin which could result in a higher serum level.]
[J04AB02, rifampin, The metabolism of Pentoxifylline can be increased when combined with Rifampicin.]
[G02CA01, ritodrine, The risk or severity of adverse effects can be increased when Ritodrine is combined with Pentoxifylline.]
[N02BA05, salicylamide, The risk or severity of bleeding can be increased when Salicylamide is combined with Pentoxifylline.]
[A07EC01, sulfasalazine, The risk or severity of bleeding can be increased when Sulfasalazine is combined with Pentoxifylline.]
[S01BC08, salicylic acid, The risk or severity of bleeding can be increased when Salicylic acid is combined with Pentoxifylline.]
[N05CA06, secobarbital, The serum concentration of Pentoxifylline can be decreased when it is combined with Secobarbital.]
[N04BD01, selegiline, The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Pentoxifylline.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Obinutuzumab.]
[J01GB08, sisomicin, Pentoxifylline may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Pentoxifylline may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Pentoxifylline may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[C07AA07, sotalol, The risk or severity of adverse effects can be increased when Sotalol is combined with Pentoxifylline.]
[L01CD04, cabazitaxel, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Cabazitaxel.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
